Latest
-
16:49
Optimizing Athlete Performance Off the Field
Michael Bapis, Vios Group Private Advisor and Head of the Sports...
-
01:30
A Sticky Situation for the ECB
Inflation data from Germany and Spain has raised the prospect that price growth across the eurozone may be hotter than originally projected. Does this raise the probability of another rate hike by the ECB in September? CME Group Senior Economist Erik Norland explains. CME Group experts regularly share insights and analysis on market events that matter to you.
-
00:55
Tema Launches Two ETFs Focused on Curing...
Tema announced the addition of two new actively managed thematic ETFs: the Oncology ETF (CANC) and Global Royalties ETF (ROYA). CEO Maurits Pot weighs in on why oncology is “the biggest biotech megatrend” and ways that global royalties can “deliver equity-like returns with contractually supported income.”
-
06:46
Our insights on investing in artificial...
In this video three of our technology portfolio managers share their insights on AI investing. They cover its history, explain what it is, how it’s currently being used and how it’s evolving. In addition, our managers discuss AI’s global economic impact and where the opportunities lie. They caution against the hype surrounding AI, and recommend focusing on long-term secular winners.
-
01:46
Mirae: Rate Cuts Are a Second-Half 2024 Story
Investors need to temper their expectations for rate cuts according to Rahul Chadha, Chief Investment Officer of Mirae Asset Global Investments. Speaking on Bloomberg Markets earlier today, he pointed to labor strikes around the world and sticky wages as headwinds for Central Bankers in the near to medium term.
-
02:06
Another Boost for 10-Year Yields
Over the last four months, U.S. 10-year yields have risen from 3.35% to 4.30%. Jim Iuorio says, the driver of the rise seems to be a persistent fall in inflation coupled with surprising resilience in other non-inflation data. Analyze the probabilities of changes to the Fed rate and U.S. monetary policy, as implied by 30-day Fed Funds Futures pricing data.
